Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact Us
 
Early Edition  //  Current Issue  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited

Online ISSN 2521-8743
  About the Journal
    » About Journal
    » Editorial Board
  Authors
    » Online Submission
    » Guidelines for Authors
    » Download Templates
    » Copyright Agreement
  Reviewers
    » Guidelines for Reviewers
    » Online Peer Review
    » Online Editor Work
  Editorial Office
  Virtual Special Issues
     Drug Design

Default Latest Most Read
Please wait a minute...
For Selected: Toggle Thumbnails
Recent Advances on Molecular Modeling Studies of Transient Receptor Potential Ankyrin 1
Carita Sallomy, Maija Lahtela-Kakkonen, and Juri M. Timonen
Medicine Research    2021, 5 (1): 200021-200021.   DOI: 10.21127/yaoyigc20200021
Abstract318)      PDF (753KB)(370)       Save
Transient receptor potential ankyrin 1 (TRPA1) is an ion channel involved in nociception. In addition, TRPA1 activation triggers an inflammatory response, which intensifies the sensation of pain. The role of TRPA1 in pain makes it an attractive target for painkiller drug design. The research on TRPA1 antagonists and agonists has increased in recent years with the focus on discovering novel and effective TRPA1 antagonists. This minireview describes some computational drug design methods that have been applied for examining TRPA1 and its ligands. So far, three ligand binding sites have been proposed for TRPA1. The binding of various ligands into TRPA1 has been explored with molecular docking and molecular dynamics. This is the first review that con-centrates on TRPA1 computational studies.
Related Articles | Metrics
沪ICP备15041762号-3
Copyright © Medicine Research, All Rights Reserved.
Address: 425 East 76th Street, Apt 9E, New York, NY, 10021, United States